Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010. - Wikidata - wikimedia - TriplyDB

Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.

Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.

http://www.wikidata.org/entity/Q30429825

about

Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study Spatial Transmission of 2009 Pandemic Influenza in the US The avian influenza vaccine Emerflu. Why did it fail?Estimating the potential effects of a vaccine program against an emerging influenza pandemic--United States Protective effects of influenza A (H1N1) pandemic 2009 vaccination against the onset of influenza-like illness and asthma exacerbation in Japanese children.Modeling receipt of influenza A(H1N1)pdm09 vaccinations among US children during the 2009-2010 flu season: findings from the 2010 National Health Interview Survey Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.Policy perspectives on post pandemic influenza vaccination in Ghana and Malawi.Development of clade-specific and broadly reactive live attenuated influenza virus vaccines against rapidly evolving H5 subtype viruses.Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions The prospects and challenges of universal vaccines for influenza Animal models for influenza viruses: implications for universal vaccine development Optimizing Real-Time Vaccine Allocation in a Stochastic SIR Model Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.Influenza vaccines: from whole virus preparations to recombinant protein technology.Influenza vaccines differentially regulate the interferon response in human dendritic cell subsets.Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons.Influenza and Other Respiratory Viruses. From the Editor's desk.Clinician-initiated research on treating the host response to pandemic influenza.Willingness to Pay for an Ebola Vaccine during the 2014-2016 Ebola Outbreak in West Africa: Results from a U.S. National Sample.The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.Randomized Quality Improvement Trial of Opting-In Versus Opting-Out to Increase Influenza Vaccination Rates during Pregnancy

P2860

Q21144595-37FE18A5-045C-46C4-923F-84FB572EAE99 Q27322422-398F9F6F-1C8A-470B-8DC7-B42B81F576DE Q30203302-78445B43-48EB-44B8-B521-C5C88B27D51C Q30204154-8F33DA74-151E-4ADC-BB5E-2767F673D4BB Q30361429-4071DEBE-CD08-4D85-BB6A-E93ABA6684E9 Q30369900-5F3F9DEA-6858-4FB9-8E16-66B28D55EB18 Q30373099-0A7232E7-EF33-44CD-93E9-E958AC4A51EC Q30399227-B607D078-0D6F-443A-9783-65153EB76AEB Q30401838-D0EF8277-3759-4FE0-9832-31E00CAD3290 Q30402629-D71EED90-9A65-4B61-A86D-9D2BFE939DA7 Q30430703-918FF57A-548C-44AE-ACBD-880087275727 Q34809686-B2BFD4D3-71F8-4F09-8670-242D95FC89D6 Q35979386-2AEDBB49-F991-4980-B067-CC615DA8E824 Q37394266-A1C366B0-81D7-4455-AE3B-FE2A5214B4F7 Q38160083-FA88DD02-E284-449E-9E0D-CED9F6494FC7 Q41045747-6662C2FF-6095-46FC-B381-2233CC1D9DA3 Q41053454-8955C889-A187-49B5-B57A-C3F25D67FD2F Q42580056-8F865E52-442F-4F9C-B817-D332330F9CBE Q44105968-33F0B68A-0F59-4B3A-AE9C-4794965E5FF2 Q47553674-6D804FE1-37E3-485A-BE20-65C6D7AD3DDC Q47576940-E4ECDEEE-E7D0-47BE-93E9-912530BC93BB Q57094355-11CE856F-E3A0-4102-9382-C9C20D9B769E

P2860

Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.

http://www.wikidata.org/entity/Q30429825

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Effects of vaccine program aga ...... rus, United States, 2009-2010.

@ast

Effects of vaccine program aga ...... rus, United States, 2009-2010.

@en

type

label

Effects of vaccine program aga ...... rus, United States, 2009-2010.

@ast

Effects of vaccine program aga ...... rus, United States, 2009-2010.

@en

prefLabel

Effects of vaccine program aga ...... rus, United States, 2009-2010.

@ast

Effects of vaccine program aga ...... rus, United States, 2009-2010.

@en

P1433

Q30429825-24312DF9-AA88-46FC-8C3B-BBFD131E8AF1

P1476

Q30429825-4FB8ABDC-BFBE-4977-8615-BB25B6D8D18E

P2093

Q30429825-1E34982E-97C5-4C8C-A594-B68E61024869

Q30429825-31FB886D-F27B-4A2A-8DF7-203C2AEC7A26

Q30429825-5FBF68F8-30AF-40BD-91BB-E3E52C5974D1

Q30429825-780BA9AF-89F0-4E66-AFEB-F18421346658

Q30429825-A94F4EFB-26F0-4861-BFDE-3BBE4A26D2FA

Q30429825-B5B641BF-D675-44FF-94B1-8921569B34AF

P2860

Q30429825-01EFF726-B6B8-467F-9F60-5F72AC9032DA

Q30429825-119C8AFF-4C8C-4CD4-AD41-FE1F01DD2D9B

Q30429825-122FE83B-08B0-43CD-AF95-DEB18BB4850A

Q30429825-18B826A6-B784-4ED1-BDD6-892815907BBE

Q30429825-1ED990C6-5575-4D16-85E2-58E8F2723A11

Q30429825-24A0A788-FB72-44AB-8895-C548F332F936

Q30429825-3F92BF22-4B3D-4D5E-88EA-7EC4B56D8015

Q30429825-52FFC2E6-4CE7-41BA-B280-083254E04724

Q30429825-53EFB668-5861-486E-818B-D04BA369C132

Q30429825-549AD928-4D53-479A-BA3B-88A549FC4251

P304

Q30429825-A0AB84D1-CE14-4560-9E06-F167C062947A

P31

Q30429825-92BE6CC2-39DA-4F5C-A562-483D967000FB

P356

Q30429825-AB40F333-D9C3-43CF-8340-7FC2E8B54FE8

P433

Q30429825-C7ED6FB5-6DE7-4ACA-BA8B-D5B0697F02C5

P478

Q30429825-E8A9BA80-9359-452B-BB85-8483C777B4BC

P50

Q30429825-CECC612F-4639-436C-B151-223E7491344A

P577

Q30429825-BE14C851-F98F-4188-9C8F-A5A24FCD7AAA

P5875

Q30429825-000BFD4F-D54C-433F-842E-9F519EC0B5A7

P698

Q30429825-ACACF932-44DE-431B-B97E-A129789756B4

P921

Q30429825-82E1E807-D524-488F-BFC3-73F65774B010

Q30429825-F55BADA8-37A3-483B-B70D-DFAC49160387

P932

Q30429825-E2E30533-1601-4317-AD67-0D52086DE2EF

P356

P1433

Emerging Infectious Diseases

P1476

Effects of vaccine program aga ...... rus, United States, 2009-2010.

@en

P2093

Anthony E Fiore

http://www.w3.org/2001/XMLSchema#string

Carolyn Furlow

http://www.w3.org/2001/XMLSchema#string

Charisma Y Atkins

http://www.w3.org/2001/XMLSchema#string

James A Singleton

http://www.w3.org/2001/XMLSchema#string

Rebekah H Borse

http://www.w3.org/2001/XMLSchema#string

Sundar S Shrestha

http://www.w3.org/2001/XMLSchema#string

P2860

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

The science behind preparing and responding to pandemic influenza: the lessons and limits of science.

Public health. Will vaccines be available for the next influenza pandemic?

Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009.

Update on influenza A (H1N1) 2009 monovalent vaccines.

Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009.

Interim results: influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination coverage among health-care personnel - United States, August 2009-January 2010.

Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.

Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets.

P304

439-448

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1903.120394

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Martin I Meltzer

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236457931

http://www.w3.org/2001/XMLSchema#string

P698

23622679

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

3647645

http://www.w3.org/2001/XMLSchema#string